Both in Pharmaceuticals
PDS Biotechnology vs Polaryx Therapeutics
Over the past year PDSB returned +57.3% and PLYX returned −94.6%; their daily moves had a correlation of 0.01.
PDSB +57.3% PLYX −94.6%Growth of $1, one year, split-adjusted
| Metric | PDSB | PLYX |
|---|---|---|
| Price | $1.30 | $1.88 |
| Market cap | $94.2M | $93.7M |
| Today | +22.07% | +3.30% |
| 1 month | +69.7% | −7.8% |
| 6 months | +20.4% | −66.6% |
| Year to date | +68.9% | — |
| 1 year | +41.4% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $1.2M | $11.5M |
| Dividend yield | — | — |
| Volatility (60d) | 313.8% | 68.3% |
| Short % of float | 6.5% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).